help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerstenfeld, L. C.
Right arrow Articles by Lian, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerstenfeld, L. C.
Right arrow Articles by Lian, J. B.

Endocrinology, Vol 126, 1599-1609, Copyright © 1990 by Endocrine Society


ARTICLES

Effect of 1,25-dihydroxyvitamin D3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology

LC Gerstenfeld, CM Kelly, M Von Deck and JB Lian
Department of Orthopedic Surgery, Harvard Medical School, Boston, Massachusetts 02115.

Chondrocytes, derived from a tissue that remains as permanent hyaline cartilage in vivo (embryonic chicken caudal sterna) were treated with 10(-8) to 10(-8) M 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. These nonadherent rounded chondrocytes acquired an adherent, polygonal morphology in a dose-dependent fashion with 1,25(OH)2D3 treatment. During the first 4 days of 1,25(OH)2D3 treatment cell flattening was associated with a 10-fold increase in beta-actin and fibronectin and their corresponding messenger RNAs (mRNAs). After adherence over the 12 days of continuous hormone treatment, a 2- to 4-fold increase in DNA synthesis and DNA accumulation were observed for the highest hormone dose (10(-8) M). Over the same time course total collagen synthesis decreased 35-50% primarily due to decreased type II collagen synthesis, which accompanied comparable decreases in its mRNA. In contrast, both alpha 1(I) and alpha 2(I) showed a continuous 5- to 10-fold increase; however, type I collagen protein synthesis remained undetectable, indicating translational control of the type I collagen synthesis. alpha 1(X) mRNAs showed a 2- 3-fold increase after 12 days of hormone treatment, and its polypeptide was clearly detected by sodium dodecyl sulfate polyacrylamide gel analysis. Type IX collagen synthesis showed a 2-fold increase in synthesis and its mRNA levels during the first 4 days of 1,25(OH)2D3 treatment but thereafter had levels comparable to control cultures. Analysis of proteoglycan synthesis and core protein mRNA levels showed there was a 2-fold increase in core protein mRNAs while proteoglycan synthesis, as assessed by 35S incorporation, showed only a 10-20% increase. Direct hormone effects vs. those secondary to altered cellular morphology were determined by blocking cell adherence by growth of the 1,25(OH)2D3-treated cultures on bacteriological petri dishes. All of the observed effects on cytoskeletal and collagen mRNAs were blocked except the elevations observed in proteoglycan core protein and alpha 1(IX) mRNAs. DNA contents in hormone-treated cultures also remained elevated. These results suggest that 1,25(OH)2D3 both activates and suppresses specific genes, promoting chondrocyte maturation toward a more hypertrophic phenotype. However, prevention of the initial morphological alterations that are induced by 1,25(OH)2D3 blocks many of the subsequent changes in connective tissue expression.


This article has been cited by other articles:


Home page
EndocrinologyHome page
O. Garach-Jehoshua, A. Ravid, U. A. Liberman, and R. Koren
1,25-Dihydroxyvitamin D3 Increases the Growth-Promoting Activity of Autocrine Epidermal Growth Factor Receptor Ligands in Keratinocytes
Endocrinology, February 1, 1999; 140(2): 713 - 721.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
L. C Tetlow, S. J Smith, E B. Mawer, and D. E Woolley
Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes
Ann Rheum Dis, February 1, 1999; 58(2): 118 - 121.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Jingushi, A. Iwaki, O. Higuchi, Y. Azuma, T. Ohta, J.-I. Shida, T. Izumi, T. Ikenoue, Y. Sugioka, and Y. Iwamoto
Serum 1{alpha},25-Dihydroxyvitamin D3 Accumulates into the Fracture Callus during Rat Femoral Fracture Healing
Endocrinology, April 1, 1998; 139(4): 1467 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. A. Sims, C. P. White, K. L. Sunn, G. P. Thomas, M. L. Drummond, N. A. Morrison, J. A. Eisman, and E. M. Gardiner
Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo
Mol. Endocrinol., October 1, 1997; 11(11): 1695 - 1708.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
T. MCALINDON and D. T FELSON
Nutrition: risk factors for osteoarthritis
Ann Rheum Dis, July 1, 1997; 56(7): 397 - 400.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society